Zoetis Inc.
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
FIGI: BBG0039320N9
ZTS
Zoetis Inc.
GICS: 35202010
·
Sektor: Healthcare
·
Sub-Sektor: Drug Manufacturers—Specialty & Generic
NAME
Zoetis Inc.
ISIN
US98978V1035
TICKER
ZTS
MIC
XNYS
REUTERS
ZTS.N
BLOOMBERG
ZTS US
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Di., 19.11.2024
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 11:30 a.m. ET.
Investors and other interested parties will be able to access a live...
Mo., 11.11.2024
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) today announced the appointment of Jamie Brannan to a newly created role of Chief Commercial Officer, overseeing all commercial markets across the globe for the world’s leading animal health company. In this new role, Mr. Brannan will lead an evolved commercial organizational structure that will accelerate the company’s long...
Do., 07.11.2024
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 3:00 p.m. GMT.
Investors and other interested parties will be able to access a live audio ...
Mo., 04.11.2024
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2024 and raised its full year 2024 guidance for revenue and adjusted EPS.
The company reported revenue of $2.4 billion for the third quarter of 2024, an increase of 11% compared with the third quarter of 2023. On an operational1 basis, revenue for the third quart...
Do., 10.10.2024
Zoetis
US98978V1035
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the fourth quarter of 2024. The dividend will be paid on Tuesday, December 3, 2024, to all holders of record of the Company’s common stock as of the close of business on Thursday, October 31, 2024.
About Zoetis
As the world’s leading animal health co...
Do., 26.09.2024
Zoetis
US98978V1035
Zoetis and Danone recently announced a joint business development plan to drive sustainable practices on today’s dairy farms through the power of genetics for healthier cows. Combining Danone’s commitment to environmental stewardship with Zoetis’ expertise in animal genetics, the partnership aims to innovate the dairy industry’s approach to breedi...
Do., 19.09.2024
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Monday, November 4, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2024 financial results and respond to questions from financial analysts during the call.
Investors and ...
Di., 20.08.2024
Zoetis
US98978V1035
Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024. Kristin Peck, Chief Executive Officer, and Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 1:05 p.m. ET.
Investors and o...
Informationen zu Product Placements
